MedAdvisor, Zuellig Pharma in JV to market medication management solutions in Asia

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

Business News News

Business Business Latest News,Business Business Headlines

AUSTRALIAN medication platform MedAdvisor and healthcare service provider Zuellig Pharma have formed a 50:50 Singapore-based joint venture (JV) ZP MedAdvisor (ZPM) to commercialise MedAdvisor’s platform across Asia. Read more at The Business Times.

AUSTRALIAN medication platform MedAdvisor and healthcare service provider Zuellig Pharma have formed a 50:50 Singapore-based joint venture ZP MedAdvisor to commercialise MedAdvisor’s platform across Asia.

ZPM has signed a software licence agreement for its medication management solutions on an exclusive basis for eight key markets - Singapore, Thailand, Indonesia, South Korea, Taiwan, Hong Kong, the Philippines and Malaysia.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 15. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

South-east Asia stocks end weaker as Trump threat jolts markets, Singapore divesBENGALURU — South-east Asian stocks closed lower on Monday (May 6) after US President Donald Trump threatened to hike tariffs on Chinese goods this week, rekindling trade tensions between Washington and Beijing, with Singapore leading the losses in the region.
Source: TODAYonline - 🏆 1. / 99 Read more »